Alexza Pharmaceuticals Inc (NASDAQ:ALXA)
CAPS Rating:
An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.
RSS Headlines
Fool UK
Recs
developments indicate it is rational to expect additional price increases now